Disclosure by Licensee. Notwithstanding the foregoing, subject to review and comment by Licensor, Licensee may disclose Licensor Proprietary Information to the extent such disclosure is reasonably necessary for (a) the development of the Compound or the Product, (b) the filing of applications for Registration, (c) the commercialization of the Compound or the Product, or (d) the filing or prosecution of a patent applications and patents relating to Improvements invented solely by Licensee or jointly by Licensee and Licensor.
Appears in 5 contracts
Samples: License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc)
